 BOULDER, Colo., May 14, 2021 GLOBE NEWSWIRE -- Viridian Therapeutics, Inc. Nasdaq: VRDN, a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by todays therapies, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer of Viridian, will present a company overview at the virtual Oppenheimer Rare Orphan Disease Summit and participate in a fireside chat at the Jefferies Virtual Healthcare Conference. 